137 related articles for article (PubMed ID: 26286263)
1. Early results from a multi-component French public-private partnership initiative to improve participation in clinical research - CeNGEPS: a prospective before-after study.
Bordet R; Lang M; Dieu C; Billon N; Duffet JP
BMC Med Res Methodol; 2015 Aug; 15():67. PubMed ID: 26286263
[TBL] [Abstract][Full Text] [Related]
2. [Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research].
Jaillon P
Bull Acad Natl Med; 2008 May; 192(5):929-37; discussion 937-9. PubMed ID: 19238783
[TBL] [Abstract][Full Text] [Related]
3. [Clinical research activity of the French cancer cooperative network: Overview and perspectives].
Dubois C; Morin F; Moro-Sibilot D; Langlais A; Seitz JF; Girault C; Salles G; Haioun C; Deschaseaux P; Casassus P; Mathiot C; Pujade-Lauraine É; Votan B; Louvet C; Delpeut C; Bardet É; Vintonenko N; Hoang Xuan K; Vo M; Michon J; Milleron B
Bull Cancer; 2017; 104(7-8):652-661. PubMed ID: 28688747
[TBL] [Abstract][Full Text] [Related]
4. Public-private partnership models in France and in Europe.
Demotes-Mainard J; Canet E; Segard L
Therapie; 2006; 61(4):325-34, 313-23. PubMed ID: 17124948
[TBL] [Abstract][Full Text] [Related]
5. [France, an attractive country for international clinical research: 2010 survey assessed by Leem (French association of pharmaceutical companies)].
Lassale C; Sibenaler C; Behier JM; Pletan Y; Courcier S
Therapie; 2011; 66(1):1-15. PubMed ID: 21466772
[TBL] [Abstract][Full Text] [Related]
6. What strategy should France implement for H2020?
Dhainaut JF; Diebolt V; Pouletty-Lefèbvre B; ; Baker A; Bassompierre F; Borel T; Braunstein D; Demotes J; François B; Huet S; Micallef J; Misse C; Molon A; Rascol O; Ravoire S; Schwartz B; Donne N; Donne N; Fusaï G; Pouletty P; Vicaut E
Therapie; 2015; 70(1):95-109. PubMed ID: 25747841
[TBL] [Abstract][Full Text] [Related]
7. [Difficulties with conducting clinical trials in France].
Zannad F; Plétan Y
Therapie; 2001; 56(4):341-7. PubMed ID: 11677850
[TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
9. [French biomedical competitiveness clusters: opportunities for public-private partnerships].
Vasmant D
Bull Acad Natl Med; 2009 Dec; 193(9):2035-43; discussion 2044. PubMed ID: 20666016
[TBL] [Abstract][Full Text] [Related]
10. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
11. Sponsored multicentric clinical research conducted in Brazil in the respiratory area - losses and gains.
Carvalho AK; Nascimento OA; Fonseca MC; Pereira ED; Jardim JR
Rev Assoc Med Bras (1992); 2016 Apr; 62(2):131-7. PubMed ID: 27167542
[TBL] [Abstract][Full Text] [Related]
12. [Attractiveness of France for international clinical research: 8th survey conducted by Leem (French association for pharmaceutical companies)].
Galaup A; Barthélémy P; Pouletty-Lefebvre B; Béhier JM; Zetlaoui J; Borel T
Therapie; 2018 Oct; 73(5):367-376. PubMed ID: 29753391
[TBL] [Abstract][Full Text] [Related]
13. [A proposal for reforming psychologists' training in France and in the European Union].
Bouchard JP
Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
[TBL] [Abstract][Full Text] [Related]
14. [France, an attractive country for international clinical research: 2008 survey assessed by Leem (French association of pharmaceutical companies)].
Lassale C; Sibenaler C; Béhier JM; Plétan Y; Courcier S;
Therapie; 2008; 63(5):345-57. PubMed ID: 19154705
[TBL] [Abstract][Full Text] [Related]
15. [GIP CeNGEPS, an agreement of clinical research operators to reinforce clinical trials' organisation in France].
Diebolt V; Jaillon P
Therapie; 2007; 62(2):129-35. PubMed ID: 17582314
[TBL] [Abstract][Full Text] [Related]
16. Clinical research sites--the underappreciated component of the clinical research system.
Califf RM
JAMA; 2009 Nov; 302(18):2025-7. PubMed ID: 19903924
[No Abstract] [Full Text] [Related]
17. The Toulouse Gérontopôle Research Center: report of activities, 2007-2011.
Gillette-Guyonnet S; Vellas B
J Alzheimers Dis; 2012; 28(3):721-32. PubMed ID: 22258518
[TBL] [Abstract][Full Text] [Related]
18. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
19. Industry-sponsored clinical research outside high-income countries: an empirical analysis of registered clinical trials from 2006 to 2013.
Murthy S; Mandl KD; Bourgeois FT
Health Res Policy Syst; 2015 Jun; 13():28. PubMed ID: 26041551
[TBL] [Abstract][Full Text] [Related]
20. [The French School of Public Health (FSPH): I. General perspectives].
Flahault A
Bull Acad Natl Med; 2007 Feb; 191(2):325-34; discussion 335-7. PubMed ID: 17969551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
